Acute Urinary Retention

Acute urinary retention (AUR) is the sudden, often painful inability to pass urine despite a full bladder. It is a common urological emergency in older men and a recognised complication of benign prostatic hyperplasia, requiring prompt bladder drainage. This entry describes the clinical entity, its main causes and contributing mechanisms, and how it relates to BPH disease progression.

Definition

Acute urinary retention is the abrupt and usually painful inability to voluntarily void despite a full bladder, relieved by immediate bladder drainage; it is distinguished from chronic urinary retention, which develops gradually and is often painless with a large residual volume.

Scope

This entry covers the definition and recognition of acute urinary retention, its distinction from chronic retention, its principal causes (with emphasis on benign prostatic obstruction), and its place as an endpoint of BPH progression. It is a reference description of the clinical entity, not procedural or individualised treatment guidance.

Core questions

• What distinguishes acute from chronic urinary retention?
• What are the principal precipitants and mechanisms of acute retention?
• How does acute retention relate to benign prostatic hyperplasia and its progression?
• Why is acute retention treated as a urological emergency?

Key concepts

• Acute vs chronic urinary retention
• Bladder outlet obstruction
• Precipitated vs spontaneous retention
• Immediate bladder drainage (catheterisation)
• AUR as a BPH progression endpoint
• Post-obstructive considerations

Mechanisms

In men, acute retention frequently reflects bladder outlet obstruction from prostatic enlargement, sometimes tipped into complete obstruction by a precipitant such as an unrelated illness, certain medications, constipation, or excessive bladder filling; retention can also be spontaneous in the course of progressive BPH (Thomas 2004; Fitzpatrick 2006). The immediate priority is decompressing the bladder by catheterisation to relieve the obstruction and pain. Because acute retention is a recognised endpoint of BPH progression, therapies that reduce prostatic volume have been shown to lower its long-term risk in men with enlarged glands (McConnell 1998).

Clinical relevance

Acute urinary retention is a clinical entity that this entry describes so readers understand its causes and its relationship to BPH progression. The material is educational and non-prescriptive: managing an episode, including bladder drainage, is an urgent clinical task carried out by qualified clinicians and is outside the scope of this reference.

Epidemiology

Acute retention is one of the more serious complications of benign prostatic hyperplasia, and its risk rises with prostate size and symptom severity. Pooled analyses of the placebo arms of BPH trials show that untreated symptomatic disease progresses over years, with a measurable incidence of acute retention (Emberton 2008), while the PLESS trial demonstrated that a 5-alpha reductase inhibitor reduced the long-term risk of retention in men with enlarged prostates (McConnell 1998).

History

Bladder drainage for retention is an ancient practice, but the modern understanding frames acute urinary retention as a quantifiable endpoint of BPH progression. Trial evidence such as PLESS (McConnell 1998) established that medical therapy could reduce its incidence in at-risk men, and systematic synthesis of placebo arms clarified the natural progression rate (Emberton 2008), informing how the complication is conceptualised and studied.

Debates

Which men with benign prostatic hyperplasia are at highest risk of acute retention?

Larger prostate volume and greater symptom severity are associated with higher retention risk, and trial data show medical therapy can lower that risk in enlarged glands, but predicting which individual will experience retention remains imperfect.

Key figures

• John M. Fitzpatrick
• Mark Emberton
• Roger S. Kirby

Seminal works

• mcconnell-1998
• fitzpatrick-2006
• emberton-2008

Frequently asked questions

What is the difference between acute and chronic urinary retention?

Acute urinary retention is a sudden, usually painful inability to void despite a full bladder and is a urological emergency, whereas chronic retention develops gradually, is often painless, and is characterised by a persistently large residual volume of urine in the bladder.

Does benign prostatic hyperplasia always lead to acute urinary retention?

No. Acute retention is a possible complication, not an inevitable one. Its risk increases with larger prostate size and more severe symptoms, and trial evidence shows that therapies which shrink the gland can reduce the long-term risk in men with enlarged prostates.